Diagnostic Accuracy of PET with Different Radiotracers versus Bone Scintigraphy for Detecting Bone Metastases of Breast Cancer: A Systematic Review and a Meta-Analysis. [PDF]
J Imaging, 2023 Due to the importance of correct and timely diagnosis of bone metastases in advanced breast cancer (BrC), we performed a meta-analysis evaluating the diagnostic accuracy of [ <sup>18</sup> F]FDG, or Na[ <sup>18</sup> F]F PET, PET(/
Zamanian M, Treglia G, Abedi I.
europepmc +5 more sources
Renal secretion of diphosphonates in rats [PDF]
Kidney International, 1975 Renal secretion of diphosphonates in rats. Diphosphonates, characterized by a P—C—P bond, are relatively new experimental drugs used for the treatment of myositis ossificans, dental calculus, nephrolithiasis and Paget's disease.
Bonjour, Jean-Philippe +2 more
core +4 more sources
Molecular theranostics: principles, challenges and controversies. [PDF]
J Med Radiat SciMolecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Currie G.
europepmc +2 more sources
Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature. [PDF]
Asian Spine Journal, 2017 There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate and intermittent parathyroid hormone (PTH) therapy become more widely prescribed to treat osteoporosis, it is important to understand their effects on ...
Acosta, Frank L +9 more
core +3 more sources
The Rehabilitation of Partially Edentulous Maxilla With Unilateral Zygomatic Implants: A Retrospective Study up to 23 Years Follow-Up. [PDF]
Clin Oral Implants ResABSTRACT Objectives This retrospective study aimed to evaluate the clinical outcomes associated with zygomatic implant (ZI) rehabilitation in partially atrophic edentulous maxillae over a mean follow‐up period of more than 10.3 years. Methods All consecutive patients underwent ZI rehabilitation between 1999 and 2020, with a minimum follow‐up period of ...
Fan S +3 more
europepmc +2 more sources
Influence of bisphosphonates on alveolar bone density: a histomorphometric analysis [PDF]
Brazilian Oral Research, 2010 This study is a histomorphometrical analysis of the influence of the bisphosphonate alendronate on alveolar bone density. Eighteen male Wistar rats were randomly assigned to a control group (n = 9) that received no medication and an experimental group (n
CONSOLARO, Alberto +3 more
core +4 more sources
In vitro study: binding of 99mTc-DPD to synthetic amyloid fibrils [PDF]
Current Issues in Pharmacy and Medical Sciences, 2015 This paper is an report of the investigation of the in vitro binding of 99mTc-DPD for synthetic amyloid fibrils used for the diagnosis of cardiac amyloidosis (CA), as compared with the use of 99mTc-HMDP and 99mTc-PPI. It also includes an inquiry into the
Carlo Aprile +4 more
core +3 more sources
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw [PDF]
Endocrinology and Metabolism, 2021 Antiresorptive-related osteonecrosis of the jaw (ARONJ) is a rare but serious adverse event of bisphosphonate or denosumab administration; it is associated with severe pain and a deteriorated quality of life.
Ha Young Kim
doaj +1 more source
Long-Term Treatment of Postmenopausal Osteoporosis [PDF]
Endocrinology and Metabolism, 2021 Osteoporosis is an incurable chronic condition, like heart disease, diabetes, or hypertension. A large gap currently exists in the primary prevention of fractures, and studies show that an estimated 80% to 90% of adults do not receive appropriate ...
Jacques P. Brown
doaj +1 more source
Comparison of the Effectiveness and Hypocalcemia Risk of Antiresorptive Agents in Patients with Hypercalcemia of Malignancy. [PDF]
Endocrinol Metab (Seoul)Background Hypercalcemia of malignancy (HCM), a major metabolic complication of cancer, is often managed with bisphosphonates (BP) and, increasingly, with denosumab.
Kong SH +6 more
europepmc +2 more sources